Owner only: item control page
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial
Pantaleo, Giuseppe, Janes, Holly, Karuna, Shelly, Grant, Shannon, Ouedraogo, G. Laissa, Allen, Mary, Tomaras, Georgia D., Frahm, Nicole, Montefiori, David C., Ferrari, Guido, Ding, Song, Lee, Carter, Robb, Merlin L., Esteban, Mariano, Wagner, Ralf, Bart, Pierre-Alexandre, Rettby, Nils, McElrath, M. Juliana, Gilbert, Peter B., Kublin, James G.
and Corey, Lawrence
(2019)
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.
The Lancet HIV 6 (11), e737-e749.
Date of publication of this fulltext: 03 Sep 2021 09:34
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | The Lancet HIV | ||||
| Publisher: | ELSEVIER INC | ||||
|---|---|---|---|---|---|
| Place of Publication: | SAN DIEGO | ||||
| Volume: | 6 | ||||
| Number of Issue or Book Chapter: | 11 | ||||
| Page Range: | e737-e749 | ||||
| Date | 2019 | ||||
| Institutions | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene | ||||
| Identification Number |
| ||||
| Keywords | EFFICACY TRIAL; SOUTH-AFRICA; FOLLOW-UP; RESPONSES; MAGNITUDE; BREADTH; PRIME; ALVAC; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48094 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric